What tests should I get after a Mantle Cell Lymphoma diagnosis

Tests After a Mantle Cell Lymphoma Diagnosis

After you've been diagnosed with mantle cell lymphoma (MCL), your oncology team will order several important tests to understand your disease better and plan your treatment. Let me walk you through what to expect.

Essential Diagnostic Tests

According to the NCCN Guidelines for Mantle Cell Lymphoma, your care team should perform these key tests:

Blood Tests

• Complete Blood Count (CBC) with differential — measures your red blood cells, white blood cells, and platelets
• Comprehensive metabolic panel — checks kidney and liver function, electrolytes, and other important markers
• Lactate dehydrogenase (LDH) — an enzyme that can indicate disease burden (higher levels may suggest more active disease)
• Beta-2 microglobulin — a protein that helps predict how aggressive your lymphoma may be

Imaging Studies

• PET/CT scan (preferred) or CT scan of chest, abdomen, and pelvis (C/A/P) with contrast — shows where lymphoma is located in your body and helps determine your disease stage
• Neck CT with contrast — may be done if there's concern about lymph nodes in your neck area

Tissue Analysis (Pathology)

Your biopsy sample will be analyzed for:

• Immunophenotyping — identifies the specific markers on your lymphoma cells (CD5+, CD20+, cyclin D1+, CD23-/+)
• Ki-67 proliferation fraction — measures how fast the cancer cells are dividing (lower percentages, <30%, suggest a more favorable prognosis)
• TP53 sequencing — checks for mutations in this important gene; TP53 mutations are associated with poorer prognosis and may change your treatment approach
• SOX11 status — helps identify if you have indolent (slower-growing) disease

Cardiac and Other Tests

• Echocardiogram or MUGA scan — checks your heart function if you'll receive anthracycline-based chemotherapy (certain chemotherapy drugs can affect the heart)
• Hepatitis B testing — essential because immunotherapy and chemotherapy can reactivate hepatitis B virus
• Pregnancy testing — if you're of childbearing age and chemotherapy is planned
• Bone marrow biopsy ± aspirate — may be done in certain circumstances to assess bone marrow involvement

Why These Tests Matter

These tests serve several purposes:

1. Staging — determines how advanced your lymphoma is (Stage I-IV)
2. Prognostic assessment — helps your doctor understand how aggressive your disease is likely to be
3. Treatment planning — results guide which treatment approach is best for YOUR specific situation
4. Baseline comparison — provides measurements to compare against future scans to assess how well treatment is working

Important Questions to Ask Your Team

• Which of these tests have already been completed, and which still need to be done?
• What do my specific test results show, and what do they mean for my prognosis?
• Do I have any genetic mutations (like TP53) that might affect my treatment options?
• When will we have all results, and when can we discuss treatment planning?
• Are there any clinical trials I might be eligible for based on my test results?

Moving Forward

Once all these tests are complete, your oncology team will have a comprehensive picture of your disease. This information is crucial for determining whether you need immediate treatment or if active surveillance (careful monitoring without treatment) might be appropriate for your situation.

According to NCCN Guidelines, the approach depends on factors like your disease stage, whether you have symptoms, and specific biomarkers like TP53 status and Ki-67 proliferation fraction.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.